Core Viewpoint - The current demand for dental implants is weak, with no significant recovery observed in the third quarter, particularly in the private market, which faces cost-cutting pressures and intense competition [1] Company Summary - Zhenghai Biological (300653) announced on October 27 that the dental implant market is currently experiencing low demand, with no notable recovery trends in the third quarter [1] - The company noted that the private market is particularly cold, facing significant pressure to reduce costs at the end-user level, leading to fierce product competition [1] - The company's oral repair membrane products maintain a relatively stable market position, while its bone repair materials have seen an increase in market share [1] - The oral segment remains a key focus for the company, which plans to continue deepening its efforts in this area, accelerate the launch and promotion of new products, and enhance market competitiveness through the synergistic capabilities of its membrane and powder product combinations [1]